Publications by authors named "J N Ingle"

Claim this Profile
R
Reply to: "Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer" and "CDK4/6 Inhibitors in Estrogen Receptor-Low Breast Cancer".
Matthew P Goetz, Grace M Choong, Tanya L Hoskin, Judy C Boughey, Sameera R Wijayawardana, James N Ingle

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial.
Andrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel, Annapoorna Venkatachalam, Annabella R Strathman, James N Ingle

NPJ Breast Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.
Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta, John M S Bartlett, Tammy Piper, James N Ingle

Breast Cancer Res Treat· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Molecule-Mediated Photothermal Therapy Induces Apoptosis in Cancer Cells.
Asima Sahu, Jaypalsing Ingle, Reha Panigrahi, Sudipta Basu

ChemMedChem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast Cancer.
Grace M Choong, Tanya L Hoskin, Judy C Boughey, James N Ingle, Matthew P Goetz

J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis